Stay updated on ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3, signaling a small release update to the page.
    Difference
    0.1%
    Check dated 2026-07-03T23:53:36.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, signaling a backend/template update applied to the study page rather than a change to the clinical trial data.
    Difference
    0.1%
    Check dated 2026-06-26T22:26:49.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added new help/navigation sections: How to Read a Study Record, Common Questions, and How to Join a Study, and standardized the Intervention/Treatment heading. The previous revision note Revision: v3.5.5 was removed and replaced with Revision: v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T12:20:35.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5, indicating a newer page build. This reflects a newer version of the page release.
    Difference
    0.1%
    Check dated 2026-06-05T08:26:03.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Updated revision tag from v3.5.3 to v3.5.4, indicating a newer version of the page metadata.
    Difference
    0.1%
    Check dated 2026-05-15T04:13:59.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.2 to v3.5.3, indicating a small update to the page's revision history and release notes.
    Difference
    0.1%
    Check dated 2026-04-30T18:34:41.000Z thumbnail image

Stay in the know with updates to ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.